Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 25 | 2022 | 855 | 4.710 |
Why?
|
| Amyloid beta-Peptides | 15 | 2021 | 246 | 4.160 |
Why?
|
| Amyloid beta-Protein Precursor | 19 | 2022 | 137 | 3.650 |
Why?
|
| Plaque, Amyloid | 11 | 2021 | 65 | 2.550 |
Why?
|
| Mice, Transgenic | 37 | 2024 | 4143 | 2.530 |
Why?
|
| Brain | 20 | 2023 | 4113 | 1.800 |
Why?
|
| Hippocampus | 10 | 2022 | 915 | 1.750 |
Why?
|
| Dependovirus | 6 | 2021 | 135 | 1.710 |
Why?
|
| Neurons | 12 | 2022 | 2287 | 1.450 |
Why?
|
| Amyloid | 6 | 2020 | 97 | 1.440 |
Why?
|
| Tetracycline | 5 | 2024 | 90 | 1.420 |
Why?
|
| Amyloidosis | 3 | 2019 | 176 | 1.280 |
Why?
|
| Integrases | 2 | 2022 | 262 | 1.190 |
Why?
|
| Spatial Memory | 2 | 2017 | 41 | 1.180 |
Why?
|
| Spatial Learning | 2 | 2017 | 16 | 1.130 |
Why?
|
| Disease Models, Animal | 22 | 2024 | 7222 | 1.120 |
Why?
|
| Transduction, Genetic | 4 | 2016 | 475 | 1.120 |
Why?
|
| Transgenes | 8 | 2024 | 557 | 1.060 |
Why?
|
| Doxycycline | 4 | 2024 | 178 | 1.050 |
Why?
|
| Mice | 46 | 2024 | 34495 | 1.030 |
Why?
|
| Tauopathies | 1 | 2024 | 63 | 0.910 |
Why?
|
| Entorhinal Cortex | 3 | 2022 | 24 | 0.890 |
Why?
|
| Animals | 54 | 2024 | 59536 | 0.860 |
Why?
|
| Membrane Proteins | 6 | 2024 | 2819 | 0.830 |
Why?
|
| Genetic Vectors | 5 | 2021 | 1694 | 0.820 |
Why?
|
| tau Proteins | 3 | 2024 | 216 | 0.780 |
Why?
|
| Trans-Activators | 4 | 2024 | 1555 | 0.770 |
Why?
|
| Nerve Tissue Proteins | 5 | 2024 | 1491 | 0.740 |
Why?
|
| Mice, Inbred C57BL | 16 | 2018 | 6942 | 0.740 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 35 | 0.700 |
Why?
|
| Behavior, Animal | 3 | 2018 | 709 | 0.600 |
Why?
|
| Genetic Therapy | 3 | 2021 | 1616 | 0.570 |
Why?
|
| Growth Substances | 4 | 2001 | 300 | 0.560 |
Why?
|
| Neuromuscular Diseases | 1 | 2016 | 63 | 0.560 |
Why?
|
| Microglia | 5 | 2023 | 164 | 0.530 |
Why?
|
| Vesicular Transport Proteins | 1 | 2016 | 135 | 0.530 |
Why?
|
| Immunization, Passive | 2 | 2018 | 172 | 0.520 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 907 | 0.510 |
Why?
|
| Kallikreins | 1 | 2015 | 84 | 0.510 |
Why?
|
| Temporal Lobe | 1 | 2016 | 192 | 0.500 |
Why?
|
| Nestin | 1 | 2014 | 42 | 0.490 |
Why?
|
| Long-Term Potentiation | 3 | 2000 | 176 | 0.490 |
Why?
|
| Spatial Navigation | 1 | 2014 | 24 | 0.480 |
Why?
|
| Cytokines | 5 | 2001 | 2809 | 0.480 |
Why?
|
| Presenilin-1 | 7 | 2016 | 71 | 0.470 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 73 | 0.460 |
Why?
|
| Nerve Net | 1 | 2016 | 257 | 0.450 |
Why?
|
| Maze Learning | 5 | 2016 | 132 | 0.450 |
Why?
|
| Gene Transfer Techniques | 2 | 2014 | 716 | 0.440 |
Why?
|
| Locomotion | 1 | 2012 | 84 | 0.420 |
Why?
|
| Cognition | 1 | 2018 | 968 | 0.410 |
Why?
|
| Neurogenesis | 1 | 2013 | 238 | 0.400 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 1546 | 0.390 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2012 | 113 | 0.390 |
Why?
|
| Mosaicism | 1 | 2013 | 272 | 0.390 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 621 | 0.360 |
Why?
|
| Mutation | 9 | 2024 | 15179 | 0.350 |
Why?
|
| Environment | 2 | 2014 | 190 | 0.350 |
Why?
|
| Electroencephalography | 1 | 2014 | 898 | 0.350 |
Why?
|
| Brain Chemistry | 2 | 1999 | 145 | 0.350 |
Why?
|
| Synapses | 3 | 2020 | 509 | 0.350 |
Why?
|
| Cell Division | 1 | 2013 | 2489 | 0.350 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 4053 | 0.340 |
Why?
|
| Mice, Inbred C3H | 3 | 2016 | 385 | 0.330 |
Why?
|
| Seizures | 3 | 2014 | 989 | 0.320 |
Why?
|
| Astrocytes | 5 | 2016 | 368 | 0.310 |
Why?
|
| Mice, Inbred ICR | 2 | 2021 | 239 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 264 | 0.300 |
Why?
|
| Animals, Newborn | 4 | 2016 | 1338 | 0.300 |
Why?
|
| Amyloid Precursor Protein Secretases | 3 | 2014 | 99 | 0.290 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2017 | 15 | 0.290 |
Why?
|
| Injections, Intraventricular | 2 | 2016 | 114 | 0.260 |
Why?
|
| Galactosides | 2 | 2015 | 26 | 0.260 |
Why?
|
| Genes, Reporter | 2 | 2019 | 798 | 0.250 |
Why?
|
| Mental Disorders | 1 | 2012 | 862 | 0.250 |
Why?
|
| Cognition Disorders | 2 | 2014 | 786 | 0.250 |
Why?
|
| Fear | 3 | 2016 | 254 | 0.240 |
Why?
|
| Paralysis | 1 | 2024 | 51 | 0.240 |
Why?
|
| Models, Neurological | 2 | 2016 | 225 | 0.240 |
Why?
|
| Housing, Animal | 1 | 2003 | 38 | 0.240 |
Why?
|
| Male | 21 | 2021 | 123000 | 0.230 |
Why?
|
| Humans | 33 | 2024 | 261506 | 0.230 |
Why?
|
| Solubility | 2 | 2018 | 242 | 0.230 |
Why?
|
| Mice, Knockout | 3 | 2024 | 5710 | 0.230 |
Why?
|
| Analysis of Variance | 4 | 2016 | 2307 | 0.220 |
Why?
|
| Demyelinating Diseases | 1 | 2023 | 77 | 0.220 |
Why?
|
| Cell Differentiation | 1 | 2013 | 4078 | 0.220 |
Why?
|
| Endopeptidases | 1 | 2003 | 220 | 0.210 |
Why?
|
| Nervous System | 1 | 2002 | 165 | 0.200 |
Why?
|
| Complement C3 | 3 | 2020 | 78 | 0.200 |
Why?
|
| Female | 18 | 2021 | 141928 | 0.200 |
Why?
|
| Motor Neuron Disease | 2 | 2016 | 16 | 0.200 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 558 | 0.200 |
Why?
|
| Signal Transduction | 3 | 2018 | 11965 | 0.200 |
Why?
|
| Respiration | 1 | 2023 | 447 | 0.190 |
Why?
|
| Pilocarpine | 1 | 1999 | 21 | 0.180 |
Why?
|
| Interferon-beta | 1 | 2020 | 102 | 0.180 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 156 | 0.180 |
Why?
|
| Phosphorylation | 2 | 2019 | 4804 | 0.170 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 260 | 0.170 |
Why?
|
| Mutation, Missense | 1 | 2003 | 1152 | 0.160 |
Why?
|
| Neurofibrillary Tangles | 1 | 2017 | 24 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 2992 | 0.160 |
Why?
|
| Status Epilepticus | 1 | 1999 | 145 | 0.160 |
Why?
|
| Interleukin-6 | 2 | 2017 | 1038 | 0.150 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 26 | 0.150 |
Why?
|
| Huntington Disease | 2 | 2012 | 135 | 0.150 |
Why?
|
| Denervation | 1 | 2016 | 33 | 0.150 |
Why?
|
| Perforant Pathway | 1 | 2016 | 15 | 0.140 |
Why?
|
| Inflammation | 2 | 2024 | 2522 | 0.140 |
Why?
|
| Software | 1 | 2023 | 1321 | 0.140 |
Why?
|
| Motor Neurons | 1 | 2016 | 138 | 0.140 |
Why?
|
| Axon Initial Segment | 1 | 2016 | 22 | 0.140 |
Why?
|
| Alleles | 1 | 2022 | 2437 | 0.140 |
Why?
|
| Exploratory Behavior | 2 | 2014 | 106 | 0.140 |
Why?
|
| Motor Activity | 2 | 2017 | 693 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 7548 | 0.130 |
Why?
|
| Complement Activation | 1 | 2016 | 94 | 0.130 |
Why?
|
| Lysosomes | 1 | 2018 | 347 | 0.130 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2015 | 25 | 0.130 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 138 | 0.130 |
Why?
|
| Brain Mapping | 1 | 2019 | 644 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 276 | 0.130 |
Why?
|
| Lac Operon | 1 | 2015 | 122 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 1489 | 0.130 |
Why?
|
| Axons | 1 | 2018 | 403 | 0.130 |
Why?
|
| Receptors, Complement | 1 | 2014 | 48 | 0.130 |
Why?
|
| Protein Kinases | 1 | 2019 | 874 | 0.130 |
Why?
|
| RNA Interference | 1 | 2019 | 1408 | 0.130 |
Why?
|
| Entropy | 1 | 2014 | 37 | 0.120 |
Why?
|
| Cell Survival | 2 | 2013 | 3045 | 0.120 |
Why?
|
| Suppression, Genetic | 1 | 2014 | 67 | 0.120 |
Why?
|
| Chloride Channels | 1 | 2014 | 60 | 0.120 |
Why?
|
| Cerebral Arteries | 1 | 2014 | 73 | 0.120 |
Why?
|
| Drosophila | 1 | 2019 | 839 | 0.120 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 171 | 0.120 |
Why?
|
| Collagen Type IV | 1 | 2014 | 108 | 0.120 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 183 | 0.120 |
Why?
|
| Serotyping | 1 | 2013 | 166 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 7702 | 0.110 |
Why?
|
| Neural Inhibition | 1 | 2014 | 147 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 289 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2017 | 677 | 0.110 |
Why?
|
| Capsid | 1 | 2013 | 103 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 2216 | 0.110 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 238 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2016 | 690 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 333 | 0.110 |
Why?
|
| Mice, Inbred CBA | 1 | 2012 | 78 | 0.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 291 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 2315 | 0.110 |
Why?
|
| Rett Syndrome | 1 | 2015 | 262 | 0.110 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 52 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 4549 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 3101 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2012 | 184 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 3154 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2014 | 668 | 0.100 |
Why?
|
| Action Potentials | 1 | 2014 | 560 | 0.100 |
Why?
|
| Species Specificity | 1 | 2012 | 777 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2019 | 1589 | 0.100 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 406 | 0.100 |
Why?
|
| Peptides | 3 | 2012 | 1479 | 0.090 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2009 | 10 | 0.090 |
Why?
|
| Indoles | 1 | 2015 | 1009 | 0.090 |
Why?
|
| Atrophy | 1 | 2009 | 261 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 1471 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2020 | 2450 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2009 | 269 | 0.080 |
Why?
|
| Cell Death | 2 | 2001 | 671 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2014 | 1549 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2004 | 6150 | 0.080 |
Why?
|
| Age of Onset | 2 | 2012 | 827 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 2086 | 0.070 |
Why?
|
| Biomarkers | 1 | 2018 | 5047 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 592 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 997 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 2063 | 0.070 |
Why?
|
| Cellular Senescence | 1 | 2007 | 382 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2011 | 3536 | 0.060 |
Why?
|
| Chimera | 1 | 2004 | 145 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2003 | 44 | 0.060 |
Why?
|
| Plethysmography | 1 | 2023 | 31 | 0.060 |
Why?
|
| Disease Progression | 1 | 2015 | 6682 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 14551 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 1487 | 0.060 |
Why?
|
| Aging | 1 | 2012 | 1582 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2016 | 5637 | 0.060 |
Why?
|
| Proteins | 1 | 2012 | 1963 | 0.060 |
Why?
|
| Time Factors | 4 | 2013 | 12926 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 634 | 0.060 |
Why?
|
| Prion Diseases | 1 | 2002 | 4 | 0.060 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2002 | 21 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2001 | 886 | 0.050 |
Why?
|
| Trinucleotide Repeats | 1 | 2002 | 106 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 5377 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2023 | 309 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 7573 | 0.050 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2001 | 8 | 0.050 |
Why?
|
| Rats | 2 | 2000 | 6086 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 4233 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2001 | 221 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 109 | 0.050 |
Why?
|
| Genes | 1 | 2001 | 491 | 0.050 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1999 | 10 | 0.050 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1999 | 39 | 0.050 |
Why?
|
| Oncostatin M | 1 | 1999 | 23 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2001 | 176 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 6089 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2000 | 176 | 0.040 |
Why?
|
| Gliosis | 1 | 1999 | 41 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2000 | 245 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 1999 | 149 | 0.040 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 168 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2004 | 1442 | 0.040 |
Why?
|
| Lymphokines | 1 | 1999 | 272 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 1073 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1945 | 0.040 |
Why?
|
| Regeneration | 1 | 2001 | 279 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 29902 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 1618 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 1271 | 0.040 |
Why?
|
| Reference Values | 1 | 1999 | 1099 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2016 | 15 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 151 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2016 | 170 | 0.030 |
Why?
|
| Ion Channels | 1 | 2016 | 212 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 3203 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2016 | 260 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 3639 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 925 | 0.030 |
Why?
|
| Alanine | 1 | 2014 | 240 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 124 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 5159 | 0.030 |
Why?
|
| Viral Tropism | 1 | 2013 | 40 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 577 | 0.030 |
Why?
|
| Injections | 1 | 2013 | 285 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 663 | 0.030 |
Why?
|
| Sensory Gating | 1 | 2012 | 14 | 0.030 |
Why?
|
| Aged | 1 | 2017 | 70117 | 0.030 |
Why?
|
| Huntingtin Protein | 1 | 2012 | 60 | 0.030 |
Why?
|
| Motor Skills | 1 | 2012 | 107 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2012 | 132 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 694 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 86204 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2023 | 7226 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 32848 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2014 | 554 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 91 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 597 | 0.020 |
Why?
|
| Contrast Media | 1 | 2014 | 1472 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2009 | 850 | 0.020 |
Why?
|
| Cell Line | 1 | 2009 | 5114 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2001 | 48 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 6295 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 7551 | 0.010 |
Why?
|